Charnwood helps pharmaceutical and biotech companies around the world with their drug development programmes. : Charnwood helps pharmaceutical and biotech companies around the world with their drug development programmes A private equity firm has made a “significant” investment in a Leicestershire business which develops new drugs on behalf of other companies. Synova Capital has given its backing to Charnwood Molecular, which was founded in 1998 as a spin out from Loughborough University. Synova said Charnwood was a leader in its field, helping pharmaceutical and biotech companies around the world with their drug development programmes.